Sohee Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Quality of life outcomes with a new sustained‑release pregabalin in a phase 3 trial of peripheral neuropathic pain.
Journal: Current medical research and opinion
Published: August 20, 2026
Entrectinib attenuates LPS-induced neuroinflammation by inhibiting JNK, p38, and AKT pathways and ameliorates cognitive impairment.
Journal: Archives of pharmacal research
Published: August 20, 2024
Comparative effectiveness of lazertinib in patients with EGFR T790M-positive non-small-cell lung cancer using a real-world external control.
Journal: Scientific reports
Published: March 11, 2024
Pharmacokinetics of a New, Once-Daily, Sustained-release Pregabalin Tablet in Healthy Male Volunteers.
Journal: Clinical therapeutics
Published: February 24, 2021
Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial.
Journal: The Clinical journal of pain
Published: December 08, 2020
YH12852, a Potent and Selective Receptor Agonist of 5-hydroxytryptamine, Increased Gastrointestinal Motility in Healthy Volunteers and Patients With Functional Constipation.
Journal: Clinical and translational science
Published: August 07, 2020
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study.
Journal: The Lancet. Oncology
Published: May 02, 2019
Comparing survival functions with interval-censored data in the presence of an intermediate clinical event.
Journal: BMC medical research methodology
Published: July 23, 2018
The neutrophil-to-lymphocyte ratio makes the Heng risk model improve better the prediction of overall survival in metastatic renal cell cancer patients.
Journal: Japanese journal of clinical oncology
Published: April 09, 2018
Recommended oral sodium bicarbonate administration for urine alkalinization did not affect the concentration of mitomycin-C in non-muscle invasive bladder cancer patients.
Journal: Oncotarget
Published: March 17, 2017
Evaluation of the Efficacy of Solifenacin for Preventing Catheter-Related Bladder Discomfort After Transurethral Resection of Bladder Tumors in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective, Randomized, Multicenter Study.
Journal: Clinical genitourinary cancer
Published: February 29, 2016
Last Updated: 09/26/2026